We’re proud to have advised Accord Healthcare on its acquisition of Prothya Biosolutions. 

This transaction stands out due to its strategic relevance, multi-jurisdictional scope, and the regulatory complexity inherent to the healthcare and biopharma industry.  

Closing of the transaction is subject to regulatory approvals.  

To discuss how we can be of value in your future projects, please contact one of our team members below.